Tolerability of high-dose venlafaxine in depressed patients

Journal of Psychopharmacology

Volumn 18, Issue 2, 2004, Pages 200-204

  Harrison, C Louise ^a   Ferrier, Nicol ^a   Young, Allan H ^a  

^a ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

Side effects; SNRI; Tolerability; UKU rating scale; Venlafaxine

Indexed keywords

ANTIDEPRESSANT AGENT; NEUROLEPTIC AGENT; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VENLAFAXINE;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONCENTRATION LOSS; DRUG MEGADOSE; DRUG TOLERABILITY; DRUG WITHDRAWAL; FATIGUE; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MEMORY DISORDER; OPEN STUDY; PRIORITY JOURNAL; RATING SCALE; REMISSION; SOMNOLENCE; WEIGHT GAIN;

ADULT; AGED; BLOOD PRESSURE; CYCLOHEXANOLS; DEPRESSIVE DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; FEMALE; FORMULARIES; GREAT BRITAIN; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PRODUCT SURVEILLANCE, POSTMARKETING;

EID: 3242674216     PISSN: 02698811     EISSN: None     Source Type: Journal    
DOI: 10.1177/0269881104042621     Document Type: Article

References (16)

1. Anderson I M, Nutt D J, Deakin J F (2000) Evidence-based guidelines for treating depressive disorders with antidepressants: a revision of the 1993 British Association for Psychopharmacology guidelines. Journal of Psychopharmacol 14: 3-20
2. Costa e Silva J (1998) Randomized, double-blind comparison of venlafaxine and fluoxetine in outpatients with major depression. J Clin Psychiatry 59: 352-357
3. Cunningham L A (1997) Once-daily venlafaxine extended release (XR) and venlafaxine immediate release (IR) in outpatients with major depression. Venlafaxine XR 208 Study Group. Ann Clin Psychiatry 9: 157-164
4. Danjou P Hackett D (1995) Safety and tolerance profile of venlafaxine. Int J Clin Psychopharmacol 10: 15-20
5. Dewan M J, Anand V S (1999) Evaluating the tolerability of the newer anti-depressants. J Nerv Ment Dis 187: 96-101
6. Joffe R T, Marshall A M, Lee D K (1998) A large open-label study of venlafaxine in depressed outpatients by community-based physicians. J Clin Psychiatry 59: 515-520
7. Judd L L (1997) The clinical course of unipolar major depressive disorders. Arch Gen Psychiatry 54: 989-991
8. Lecrubier Y, Bourin M, Moon C A, Schifano F, Blanchard C, Danjou P, Hackett D (1997) Efficacy of venlafaxine in depressive illness in general practice. Acta Psychiatr Scand 95: 485-493
9. Lingjærde O, Ahltors U G, Bech P, Dencker S J, Elgen K (1987) The UKU side effect rating scale. A new comprehensive rating scale for psychotropic drugs and a cross-sectional study of side effects in neuroleptic-treated patients. Acta Psychiatr Scand 76 (Suppl 334): 1-100
10. Mackay F R, Dunn N R, Martin R M, Pearce G L, Freemantle S N, Mann R D (1999) Newer antidepressants: a comparison of tolerability in general practice. Br J Gen Prac 49: 892-896
11. Mehtonen O, Søgaard J, Roponen P, Behnke K (2000) Randomised, double-blind comparison of venlafaxine and sertraline in outpatients with major depressive disorder. J Clin Psychiatry 61: 95-100
12. Mitchell P B, Schweitzer I, Burrows G, Johnson G, Polonowita, A (2000) Efficacy of venlafaxine and predictors of response in a prospective open-label study of patients with treatment-resistant major depression. J Clin Psychopharmacol 20: 483-487
13. Murray C J, Lopez A D (1997) Global mortality, disability, and the contribution of risk factors: global burden of disease study. Lancet 349: 1436-1442
14. Rudolph R L, Fabre L F, Feighner J P, Rickels K, Entsuah R, Derivan A T (1998) A randomised, placebo-controlled, dose response trial of venlafaxine hydrochloride in the treatment of major depression. J Clin Psychiatry 59: 116-122
15. Thase M E (1997) Efficacy and tolerability of once-daily venlafaxine extended release (XR) in outpatients with major depression. The venlafaxine XR 209 Study Group. J Clin Psychiatry 58: 393-398
16. Thase M E (1998) Effects of venlafaxine on blood pressure: A meta-analysis of original data from 3744 depressed patients. J Clin Psychiatry 59: 502-508